INTRODUCTION TO THE NEW CEO

July 31st, 2013

Disclaimer

The material that follows is a presentation of general background information about RaiaDrogasil S.A. (the “Company”) as of
the date of the presentation. It is information in summary form and does not purport to be complete. It is not intended to be
relied upon as advice to potential investors. This presentation is strictly confidential and may not be disclosed to any other
person. No representation or warranty, express or implied, is made concerning, and no reliance should be placed on, the
accuracy, fairness, or completeness of the information presented herein.

This presentation contains statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933
(the “Securities Act”) and Section 21E of the Exchange Act of 1934. Such forward-looking statements are only predictions and
are not guarantees of future performance. Investors are cautioned that any such forward-looking statements are and will be, as
the case may be, subject to many risks, uncertainties and factors relating to the operations and business environments of the
Company that may cause the actual results of the companies to be materially different from any future results expressed or
implied in such forward-looking statements.

Although the Company believes that the expectations and assumptions reflected in the forward-looking statements are
reasonable based on information currently available to the Company’s management, the Company cannot guarantee future
results or events. The Company expressly disclaims a duty to update any of the forward looking-statements.
Our securities have not been and will not be registered under the Securities Act or under any state securities laws in the United
States, and are being offered under exemptions from registration under the Securities Act. Securities may not be offered or
sold in the United States unless they are registered or exempt from registration under the Securities Act. Any offering to be
made in the United States will be made by means of an offering circular that may be obtained from the agents.
This presentation does not constitute an offer, or invitation, or solicitation of an offer, to subscribe for or purchase any
securities. Neither this presentation nor anything contained herein shall form the basis of any contract or commitment
whatsoever.

In order to ensure equal information disclosure and in line with best corporate governance practices, RaiaDrogasil S.A. is on
quiet period regarding the 2Q13 results. Other questions and clarifications not related to 2Q13 results will be answered
normally.

2
CEO Succession

 Marcílio D’Amico Pousada

 Appointed CEO by the Board on July 1st, 2013

 Assumed on July 23rd, 2013

 Cláudio Roberto Ely

 Led Drogasil for 13 years and RaiaDrogasil for nearly two years

 Turns 65 years-old in January, 2014

 Concludes his cycle at RaiaDrogasil today

3
Cláudio Roberto Ely

 Assumed as Drogasil’s CEO in 1998

 Repositioned the Company and leveraged its profitability

 Listed Drogasil in the Novo Mercado segment of BM&FBovespa in 2007 and capitalized the Company

 Acquired mid size companies and turned Drogasil into a national chain (GO, DF e ES)

 Structured the association with Raia S.A. that led to the creation of RaiaDrogasil

 Headed the new Company in its growth and integration

 Acquired stores from two other regional chains to achieve the leadership in the Mid-West region

 Launched Farmasil, a new popular stores format that is being piloted 4

Succession Process

 Human Resources Committee (reports to the Board)

 Established in the formation of RaiaDrogasil in 2011

 Succession and Compensation Plans for the Company’s main levels

 Key Assumption: Continuity with Evolution

 Accelerated organic growth with operational excellence

 Preservation of RaiaDrogasil’s values, culture and management philosophy

 Continuity of the current Management Team, with vast experience in the drugstore industry

 Recruitment Process

 Expected timing: end of 2013, but its quick conclusion anticipated the leadership change

 Background: Deep retail experience

 Personal Profile: Leadership, entrepreneurism and execution capacity

5
Marcílio D’Amico Pousada

 Brazilian, 50 years-old

 CEO of Livrarias Saraiva (2005 – 2013), led the acquisition of Siciliano and the post-merger integration

 CEO and founder of OfficeNet Brasil (2000 – 2005), coordinated its sale to Staples in 2004

 Commercial Director at Submarino (1999), participated in the Company’s foundation

 Director of non-food products at Sam’s Club (Wal-Mart) (1994 – 1999)

 Worked at C&A and at Mappin early in his career (1989 – 1994)

6
Strong Corporate Governance Standard and Support of Majority Shareholders
with Long-Term Industry Vision and Commitment
Pires1 Pipponzi Janos Galvão3 Galvão3 Pipponzi Janos
Family Family Holding2 Family Family Family Holding2
(15.8%) (13.8%) (4.7%) (2.7%) (2.5%) (0.9%) (0.4%)

Shareholder Agreement
Free Shares
Lock-up on 30% or more of the Vote with the Shareholder Agreement
Company’s shares until Nov, 2021

37.0% 3.8% Free Float

59.2%
RaiaDrogasil S.A. Free Float

BOARD OF DIRECTORS

Antonio Carlos Pipponzi
Carlos Pires O. Dias
Paulo Sérgio C. Galvão
Plinio Villares Musetti
Renato Pires O. Dias
Cristiana Pipponzi
Jairo E. Loureiro
José Paschoal Rossetti
Hector Nunez
Chairman Former CEO of Raia, with 35 years of industry experience, and Board Member of Lojas Colombo
Member Board Member of the Company for over 20 years and of Grupo Camargo Correa
Member Board Member of the Company for nearly 20 years and of Klabin S.A.
Member Former Chairman of Raia, Chairman of Natura, former CEO of Elevadores Atlas
Member Board Member of the Company for over 5 years
Member Former marketing director of RaiaDrogasil and of Raia, with 10 years of industry experience
Independent Board Member of the Company for over 10 years, Board Member of Hypermarcas
Independent Board Member of Fleury, Boticário and of Quimica Amparo, Professor at Fundação Dom Cabral
Independent CEO of Ri-Happy, former CEO of the Wal-Mart Group in Brazil

1 Carlos Pires Oliveira Dias and Regimar Comercial S.A.

2 Pragma’s carve-out, Janos Holding is the long-term strategic investment group of Guilherme Leal, Luis Seabra and Pedro Passos, founders of Natura. 7
3 GL Participações Ltda